Latest filing published 03 Dec 2019 for Promore Pharma, €2.4M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Göran Linder: trading record in brief
Göran Linder discloses dealings in Promore Pharma to Finansinspektionen. Over a trading history stretching from 25 May 2018 to 28 November 2019, the count stands at 6 filings.
On the open market, the record shows 2 purchases worth €325k and 2 sales worth €161k. Purchases outweigh sales by €164k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2019 alone, the filings show 1 purchase and 1 sale.
On 3 December 2019 came the latest disclosure, a transaction for €2.4M in Promore Pharma. The latest purchase dates back some time: it was published 2,802 days ago, on 7 March 2019. The median gap between a trade and its publication by Finansinspektionen is 3 days. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Göran Linder
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,813,219 shares@ SEK 3.7193.7% of flowBTA (betald tecknad aktie)ISIN SE0013359072FI:csv-16cf58d6df127820df1c
- 515,022 shares0TeckningsoptionISIN SE0009997158FI:csv-dac1efab2e1f6ec4f682
- 140,656 shares@ SEK 12.005.9% of flowAktieISIN SE0009947740FI:csv-1e97d9c4dd8c652456eeCanonical exit: 5 Jun 2019 (T+90)
- 182,728 shares@ SEK 0.040.0% of flowAktieISIN SE0009947740FI:csv-dc7dc88fa8da8ea8881f
- 140,656 shares@ SEK 12.006.0% of flowISIN SE0009947740FI:csv-547ca6873934a25f20d2Canonical exit: 23 Aug 2018 (T+90)
5 of 5 declarations